• Latest Posts

Gamida Cell’s Bone Marrow Transplant Cuts Treatment Time in Phase III

Italian Pharma Getting Back to Normal With Two Biotech Acquisitions

Phase III Failure Sinks Drug for Rare Neurological Disorder

€7M Series A To Democratize Genomics with AI-Driven Cloud Software

EU Pitches Into €7.4B Fund Supporting Covid-19 Treatments & Vaccines

BioMarin Partners Swiss Biotech to Develop Cardiac Gene Therapies

ADVERTISEMENT

Lyme Disease Vaccine Gets Pfizer’s Backing in €284M Deal

Expert Advice 4 May 2020

How Are Biotech VC Investments Changing with Covid-19?

Startup Scout 1 May 2020

Belgian Company Harnesses Lab-on-a-Chip Technology to Diagnose Disease

Update: Kurma Partners’ Third Biofund Closes at €160M

Update: BioNTech and Pfizer’s mRNA Vaccine for Covid-19 Tested in Humans

Pluristem Scores €50M From EIB to Develop Covid-19 Cell Therapy

ADVERTISEMENT